Q2 2026 saw robust sales and margin growth, with EPS and Adjusted EBITDA rising year-over-year. FY2026 guidance was raised for EPS, sales, and EBITDA, reflecting strong momentum. Share repurchases and disciplined capital allocation continued.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.